Public-registry site landscape for NCT07718581, a Solid Tumor, Adult study sponsored by Hutchmed. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07718581 (registry record) |
| Sponsor | Hutchmed |
| Condition(s) | Solid Tumor, Adult |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 7 |
| Site countries | China |
At Beijing Cancer Hospital — one of the facilities listed on this trial — 26 other studies are actively recruiting Solid Tumor, Adult patients at the same facility (public registry, as of July 2026). Facility-level recruiting density is one of the strongest public correlates of enrollment pace in an indication.
Eichor generates a preliminary site-risk snapshot for NCT07718581 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →